ExploreWatchlistsPricing
  1. JP-listed companies
  2. KANEKA CORPORATION
  3. Financials
  4. Stockholders' equity

KANEKA CORPORATION (4118)

Market cap
¥339.7B
P/E ratio
10.1x
Kaneka develops advanced materials, medical devices, solar technology, and nutrition products across four business units serving infrastructure, housing, healthcare, and food industries.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndStockholders' equity (Million JPY)YoY (%)
Mar 31, 2025492,419+3.80%
Mar 31, 2024474,383+8.70%
Mar 31, 2023436,422+5.88%
Mar 31, 2022412,204+8.18%
Mar 31, 2021381,040+7.61%
Mar 31, 2020354,094-1.84%
Mar 31, 2019360,726+4.08%
Mar 31, 2018346,599+7.79%
Mar 31, 2017321,551+4.16%
Mar 31, 2016308,722-0.16%
Mar 31, 2015309,227+8.45%
Mar 31, 2014285,133

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat